Financials
- Market Capitalization 26.85 M
- Employee 16
- Founded 2013
- CEO N/A
- Website www.lanternpharma.com
- Headquarter Texas, United States
- FIGI BBG00GM6LK17
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.93
ratio cours/chiffre d'affaires
-390.6
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4477 | CVM Cel-Sci Corporation Common Stock | 1.54 USD | -4.94% | +5.48% | +27.27% | -70.10% | 27.09 M USD | ||
| 4479 | NNVC NanoViricides, Inc. Common Stock | 1.25 USD | -3.10% | -6.72% | -21.38% | +23.75% | 27.06 M USD | ||
| 4491 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.63 USD | -1.56% | -16.00% | -47.93% | -64.00% | 25.91 M USD | ||
| 4495 | EVAX Evaxion A/S - American Depositary Share | 3.06 USD | -2.86% | -8.93% | +8.90% | -7.83% | 25.52 M USD |